Cisplatin 10mg Injection – Reliable Global Supply from India
Cordium Pharmaceuticals Pvt Ltd, a trusted global exporter based in India, offers high-quality Cisplatin 10mg Injection, widely used in oncology treatments. With a strong distribution network, we ensure fast and secure delivery to major international markets including the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.
What is Cisplatin 10mg Injection?
Cisplatin is a chemotherapy medication used to treat various types of cancers. It belongs to the class of platinum-containing compounds that work by stopping the growth of cancer cells.
Usage of Cisplatin 10mg Injection
Cisplatin is commonly prescribed for:
Testicular cancer
Ovarian cancer
Bladder cancer
Lung cancer
Cervical cancer
Head and neck cancers
It is often used alone or in combination with other chemotherapy drugs depending on the treatment protocol.
Dosage Information
Dosage is strictly determined by a qualified oncologist.
It depends on the patient’s condition, body weight, and response to treatment.
Administered via intravenous infusion under medical supervision.
Adequate hydration is essential before and after administration to reduce toxicity risks.
Note: Always follow your doctor’s prescription. Self-medication is not advised.
Possible Side Effects
Like all chemotherapy drugs, Cisplatin may cause side effects, including:
Nausea and vomiting
Kidney toxicity (nephrotoxicity)
Hearing loss (ototoxicity)
Low blood cell counts (anemia, leukopenia)
Fatigue and weakness
Loss of appetite
Seek immediate medical attention if severe reactions occur.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted global exporter from India
Assured quality pharmaceutical products
Competitive pricing for bulk orders
Fast international delivery
Reliable supply chain across multiple countries
Contact for Bulk Orders & Export Inquiries
📞 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
Global Supply Coverage
We deliver efficiently to:
United States | Germany | United Kingdom | Netherlands | South Africa | United Arab Emirates | Brazil
